Agenda

Session I
08:45 – 09:00 Welcoming remarks
09:00 – 10:30

ORAL PRESENTATIONS OF ORIGINAL RESEARCH WORK AND OF CLINICAL CASES

At the end of this session, participants will be better able to:

  • Identify and understand the nature and results of recent research work done by their peers.
  • Discuss the results and determine the impact on practice.
10:30 – 11:00 Break
Session II
11:00 – 12:00

“The Power of the Patient Voice in Helping Us Transform Rheumatology”

Susan Bartlett, PhD

At the end of this session, participants will be better able to:

  • Describe the evolution of patient-reported outcomes (PROs) in Rheumatology.
  • Identify how PROs increase efficiency and inform goal setting and decision-making.
  • Discuss how PROs enhance patient and provider satisfaction with care.
12:00 – 13:30 Lunch
Session III
13:30 – 14:30

“Pathogenesis of Giant Cell Arteritis.”

Maria C. Cid, MD

At the end of this session, participants will be better able to provide answers to the following questions:

  • Discuss the inflammatory pathways involved in GCA and the experimental evidence supporting them.
  • Understand the unique aspects of GCA compared with other chronic inflammatory diseases.
  • Understand how pathogenesis may impact emergence o new targeted therapies in the near future and how the clinical impact of targeted therapies may add proof of concept to the pathogenesis model.
14:30 – 15:00 Break
Session IV
15:00 – 16:00

“Osteosarcopenia: Where muscle, bone and fat collide”

Gustavo Duque,MD, PhD, FRACP, FGSA

At the end of this session, participants will be better able to provide answers to the following questions:

  • Describe the pathophysiology of osteosacopenia from an interorgan communication perspective
  • Discuss the clinical phenotype of osteosarcopenia, including diagnostic criteria and biomarkers
  • Present clinical pathways to evaluate and treat older persons with osteosarcopenia.
18:00 – 19:00

Cocktail
19:00

Dinner & Awards

Jeffrey-Shiroky Award: Susan Bartlett, PhD

Roger-Demers Award: Maria C Cid, MD

Marie-Thérèse Fortin Award: Claude Marcoux, MD
Session V
09:00 – 10:30

ORAL PRESENTATIONS OF ORIGINAL RESEARCH WORK AND OF CLINICAL CASES

At the end of this session, participants will be better able to:

  • Identify and understand the nature and results of recent research work done by their peers.
  • Discuss the results and determine the impact on practice.
9:30 – 10:30

“Interstitial Lung Disease (ILD) in patients with systemic autoimmune rheumatic diseases:  a Respirologist’s perspective”

Deborah Assayag, MD, MAS

At the end of this session, participants will be better able to provide answers to the following questions:

  • Recognize the lung manifestations of autoimmune diseases.
  • Review the lung-specific investigations for ILD in autoimmune diseases.
  • Develop an approach to treatment for ILD in autoimmune disease.
10:30 – 11:00 Break
Session VI
11:00 – 12:00

“New advances in the treatment of GCA”

Maria C. Cid, MD

At the end of this session, participants will be better able to:

  • Disscuss classical treatment of GCA, its limitations and ways to overcome them.
  • Revise new advances in the treatment of GCA.
  • Discuss emerging targeted therapies with their potential advantages and limitations.
12:00 Closing remarks